Mizuno, Shohei
Hosoi, Hiroki
Takami, Akiyoshi
Kawata, Takahito
Doki, Noriko
Takeda, Wataru
Tanaka, Masatsugu
Nishida, Tetsuya
Uchida, Naoyuki
Hasegawa, Yuta
Sawa, Masashi
Ota, Shuichi
Onizuka, Makoto
Nakamae, Hirohisa
Asada, Noboru
Fukuda, Takahiro
Yoshimitsu, Makoto
Kanda, Yoshinobu
Ohbiki, Marie
Atsuta, Yoshiko
Konuma, Takaaki
Yanada, Masamitsu
Funding for this research was provided by:
Japan Agency for Medical Research and Development (19ek0510023h0003)
Japan Society for the Promotion of Science (JP24K11566)
Article History
Received: 2 September 2024
Accepted: 8 November 2024
First Online: 19 November 2024
Declarations
:
: This study was approved by the institutional review board of the Aichi Medical University and was conducted in accordance with the Declaration of Helsinki. All patients provided informed consent for the use of their clinical information for research.
: SM received research funding from Hayashikane Sangyo, and AT received research funding from Air Water, lecture fees from Novartis Pharmaceutical, and donated funds from Chugai Pharmaceutical, Kyowa Kirin, and Zenyaku Kogyo.